After TNF Failure, IL-17 Switch May Outperform TNF Cycling in PsA

Researchers conducted a single-center, retrospective study to compare two common post–biologic-failure strategies in psoriatic arthritis (PsA): cycling TNF inhibitors (TNFi→TNFi) versus swapping mechanism of action between TNFi and IL-17 inhibitors (TNFi→IL-17i or IL-17i→TNFi).

Read More> https://pocncoe.com/psoriatic-arthritis/home/article/after-tnf-failure-il-17-switch-may-outperform-tnf-cycling-in-psa/